Yoga as a non‐pharmacologic therapy to reduce dinutuximab‐induced pain in patients with neuroblastoma
- 8 January 2024
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (4) , e30845
Abstract
Background: Anti‐GD2 antibodies are key components of treatment for high‐risk neuroblastoma; however, they cause neuropathic pain. Yoga therapy may help reduce pain and distress associated with anti‐GD2 therapy. Procedure: Children 3 years of age or older with neuroblastoma participated in individualized yoga therapy while receiving the anti‐GD2 antibody dinutuximab (DIN). Yoga therapy was deemed feasible if patients participated during 60% or more of DIN admissions. Patients and caregivers assessed pain/distress before and after yoga therapy with a distress thermometer ( DT ) and Wong‐Baker FACES pain rating scale and completed questionnaires regarding satisfaction with yoga therapy. Therapy was deemed efficacious if there was a ≥1 point pain score change and reduction in distress after yoga. Results: Eighteen patients were enrolled; 52 encounters (admissions for DIN) were evaluable. Ten of 18 were female, three of 18 were Hispanic, and 10/18 were White. Median age at enrollment was 5.5 years (range: 3–11). Yoga therapy was feasible in 39/52 (75%) encounters. Significant reductions in caregiver‐reported pain and distress and reductions in patient‐reported pain and distress after yoga therapy were reported. Twelve of 18 caregivers completed questionnaires: seven agreed/strongly agreed that yoga was valuable, and nine agreed/strongly agreed to continued participation in yoga. Thirty‐four of 36 clinicians reported that they would recommend yoga therapy for other patients receiving DIN. Conclusions: Yoga therapy was feasible during DIN therapy and may be effective in reducing DIN‐associated pain and distress. Future studies are needed to evaluate changes in opioid usage with the addition of yoga therapy during anti‐GD2 antibody therapy.Keywords
This publication has 17 references indexed in Scilit:
- A Mind–Body Approach to Pediatric Pain ManagementChildren, 2017
- A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive CrisisJournal of Pain and Symptom Management, 2017
- Immunotherapy for High-Risk Neuroblastoma: Management of Side Effects and ComplicationsJournal of the Advanced Practitioner in Oncology, 2017
- Validity, specificity, feasibility and acceptability of a brief pediatric distress thermometer in outpatient clinicsPsycho-Oncology, 2015
- Acute Pain Relief After Mantram Meditation in Children With Neuroblastoma Undergoing Anti-GD2 Monoclonal Antibody TherapyJournal of Pediatric Hematology/Oncology, 2014
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for NeuroblastomaNew England Journal of Medicine, 2010
- Peaceful Play Yoga: Serenity and Balance for Children With Cancer and Their ParentsJournal of Pediatric Oncology Nursing, 2010
- Iyengar Yoga for Young Adults with Rheumatoid Arthritis: Results From a Mixed-Methods Pilot StudyJournal of Pain and Symptom Management, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Validity of Parent Ratings as Proxy Measures of Pain in Children with Cognitive ImpairmentPain Management Nursing, 2005